Biography
Jeeyoon Chung is an associate in Weil’s Technology & IP Transactions practice and is based in New York. Jeeyoon participates in advising Firm clients in a variety of matters relating to the licensing, acquisition, development, sale, use and commercial exploitation of intellectual property and technology. She also participates in advising clients regarding privacy and data security issues in the context of corporate transactions.
Jeeyoon has been part of teams advising on the technology and intellectual property aspects, as well as on the data privacy and cybersecurity aspects of the following matters:
- CIIG Capital Partners II, Inc., a SPAC sponsored by CIIG Management II LLC, in its business combination with Zapp Electric Vehicles Ltd. that implied a combined enterprise value of $573 million
- Goldman Sachs in its acquisition of NextCapital Group, Inc.
- Halozyme Therapeutics, Inc. in its $960 million acquisition of Antares Pharma, Inc.
- The Kroger Company, along with The Albertsons Companies, Inc., in the approximately $1.9 billion sale of 413 stores, as well as select banners, distribution centers, offices and private label brands, to C&S Wholesale Grocers, LLC in connection with Kroger’s proposed merger with Albertsons Companies Inc..
- Warburg Pincus, as a co-investor with One Equity Partners, in the formation of Eco Material Technologies Inc. through a business combination with Green Cement Inc. and the $1 billion acquisition of Boral Resources LLC
Jeeyoon joined Weil as a summer associate in 2020.
Jeeyoon received her J.D. from Columbia Law School, where she was a Harlan Fiske Stone Scholar, was the president of the Asian Pacific American Law Students Association and served as the Development and Diversity Editor of the Columbia Law Review, and her B.A. from Johns Hopkins University. At Columbia, she was awarded the Carol B. Liebman Mediation Prize. She is fluent in Korean and French.
Firm News & Announcements
Firm News & Announcements
- Weil Advises The Kroger Company in its Pending $24.6B Merger with Albertsons Deal Brief — October 17, 2022
- Weil Advised Halozyme Therapeutics, Inc. in its $960M Acquisition of Antares Pharma, Inc. Deal Brief — May 24, 2022